![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Greenlights Nevro Leads
FDA Greenlights Nevro Leads
April 18, 2016
The FDA has approved Nevro’s new surgical leads, which are intended for use with Senza Spinal Cord Stimulation, a neuromodulation platform delivering HF10 therapy.
The SCS therapy system delivers electrical pulses via a compact battery-powered generator implanted under the skin located near the spinal cord to treat chronic leg and back pain. — Joya Patel
Upcoming Events
-
21Oct